Adding accessibility features to digital health technologies: Enhancing inclusion and the patient experience
A clinical trial population should mimic the patient population that will ultimately use the therapy that is being studied. Sounds logical, doesn’t it? Unfortunately, this has not always been the case and there have been negative consequences.
Read this insightful article by Clario scientist, Dr. Kelly Dumais, who offers up suggestions on how technology can help solve this problem.
Kelly Dumais, PhD
Principal Scientific Advisor at Clario